CD4 and breast carcinoma: PECS II block was found to raise the numbers of CD3+, CD4+, and CD4+/CD8+ T cells in peripheral blood 3 and 24 h after breast cancer surgery in another study,59 implying that PECS II blockade can also improve cellular immune activity in patients undergoing surgery.